Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Change in Receivables (2016 - 2025)

Ultralife has reported Change in Receivables over the past 16 years, most recently at $2.9 million for Q4 2025.

  • Quarterly results put Change in Receivables at $2.9 million for Q4 2025, up 183.95% from a year ago — trailing twelve months through Dec 2025 was $4.4 million (up 157.3% YoY), and the annual figure for FY2025 was $4.4 million, up 157.3%.
  • Change in Receivables for Q4 2025 was $2.9 million at Ultralife, up from -$1.3 million in the prior quarter.
  • Over the last five years, Change in Receivables for ULBI hit a ceiling of $6.6 million in Q1 2025 and a floor of -$4.2 million in Q2 2024.
  • Median Change in Receivables over the past 5 years was -$1.3 million (2025), compared with a mean of -$62000.0.
  • Biggest five-year swings in Change in Receivables: skyrocketed 239.55% in 2022 and later tumbled 223.53% in 2023.
  • Ultralife's Change in Receivables stood at $391000.0 in 2021, then soared by 596.68% to $2.7 million in 2022, then skyrocketed by 63.55% to $4.5 million in 2023, then plummeted by 178.05% to -$3.5 million in 2024, then soared by 183.95% to $2.9 million in 2025.
  • The last three reported values for Change in Receivables were $2.9 million (Q4 2025), -$1.3 million (Q3 2025), and -$3.9 million (Q2 2025) per Business Quant data.